Hereditary Spherocytosis

Hereditary Spherocytosis is an inherited blood disorder in which red blood cells become sphere-shaped, fragile, and are broken down too early, causing hemolytic anemia. It can range from very mild to severe and is usually managed with regular monitoring, supportive care, and specialist treatment when needed.

Overview

Hereditary Spherocytosis is a genetic blood disorder that affects the outer membrane of red blood cells. Healthy red blood cells are usually flexible, disc-shaped cells that move easily through the bloodstream and spleen. In Hereditary Spherocytosis, changes in membrane proteins make red blood cells rounder, smaller, and less flexible. These abnormal cells, called spherocytes, are removed too early by the spleen, leading to hemolytic anemia.

The condition can be mild, moderate, or severe. Some people have few symptoms and are diagnosed only after a routine blood test or family screening. Others develop noticeable anemia, yellowing of the skin or eyes, fatigue, or an enlarged spleen during childhood. Symptoms may become more obvious during infections, rapid growth, pregnancy, or other times when the body needs more red blood cells.

Hereditary Spherocytosis is one of the more common inherited causes of hemolytic anemia in many populations, but its presentation varies. Because it is lifelong, care focuses on confirming the diagnosis, monitoring red blood cell breakdown, preventing complications, and choosing treatment only when the benefits outweigh the risks. Many patients live active lives with appropriate follow-up and timely medical care.

Symptoms

Hereditary Spherocytosis symptoms are mainly caused by anemia and ongoing breakdown of red blood cells. Anemia occurs when the body does not have enough healthy red blood cells to carry oxygen efficiently. Hemolysis, the early destruction of red blood cells, can also increase bilirubin, a yellow pigment that may cause jaundice.

Symptoms vary from person to person. Mild cases may cause no daily symptoms, while more significant cases can lead to episodes of tiredness, paleness, shortness of breath with exertion, or rapid heartbeat. Children may be noticed to have jaundice, poor feeding in infancy, slow growth, or an enlarged abdomen due to an enlarged spleen.

• Fatigue, weakness, or reduced exercise tolerance
• Pale skin or mucous membranes
• Jaundice, especially yellowing of the eyes
• Dark urine during episodes of increased hemolysis
• Enlarged spleen, sometimes felt as fullness or discomfort in the left upper abdomen
• Gallstones, which may cause right upper abdominal pain, nausea, or digestive discomfort
• Episodes of more severe anemia during certain viral infections

Some people experience sudden worsening of anemia during an aplastic crisis, often triggered by parvovirus B19 infection, when the bone marrow temporarily slows red blood cell production. This requires prompt medical assessment. Symptoms such as marked tiredness, dizziness, fainting, rapid heartbeat, high fever, or worsening jaundice should not be ignored.

Causes & Risk Factors

Hereditary Spherocytosis is caused by inherited changes in genes that help build and stabilize the red blood cell membrane. These genes affect proteins that keep red blood cells flexible and durable as they circulate. When these proteins do not work normally, the cell membrane becomes unstable, portions of membrane are lost, and the red blood cell takes on a sphere-like shape.

Sphere-shaped red blood cells are less able to squeeze through the spleen. The spleen recognizes them as abnormal and removes them from circulation earlier than usual. The bone marrow tries to compensate by making more red blood cells, but if destruction is faster than production, anemia develops.

The main risk factor is having a family history of Hereditary Spherocytosis or unexplained hemolytic anemia, jaundice, splenectomy, or gallstones at a young age. In many families, the condition follows an autosomal dominant inheritance pattern, meaning a child can inherit it from one affected parent. Less commonly, it may follow a recessive pattern or occur due to a new genetic change with no known family history.

Severity is not always predictable from family history alone. A parent with mild disease may have a child with more noticeable symptoms, and siblings may differ in their anemia level or complication risk. For this reason, family screening and specialist interpretation of test results can be helpful, particularly when planning care for children or future pregnancies.

Diagnosis

Diagnosis of Hereditary Spherocytosis begins with a medical history, family history, physical examination, and blood tests. The doctor may ask about anemia, jaundice, gallstones, transfusions, splenectomy in relatives, and symptoms during infections. Physical examination may look for paleness, jaundice, or enlargement of the spleen.

Initial blood tests often include a complete blood count, reticulocyte count, bilirubin level, and blood smear. A blood smear may show spherocytes, the round red blood cells typical of the condition. Reticulocytes are young red blood cells; a high count suggests that the bone marrow is working harder to replace cells being destroyed.

Additional tests may be used to confirm the diagnosis and distinguish Hereditary Spherocytosis from other causes of hemolytic anemia. These may include tests of red blood cell fragility or membrane function, such as eosin-5-maleimide binding by flow cytometry, osmotic fragility testing, or acidified glycerol lysis testing. A direct antiglobulin test may be performed to help rule out autoimmune hemolytic anemia, which can also produce spherocytes.

Genetic testing is not required for every patient, but it may be useful when the diagnosis is uncertain, the family pattern is unclear, symptoms are severe, or counseling is needed. Imaging, such as abdominal ultrasound, may be recommended to assess spleen size or look for gallstones. The final diagnosis is made by a qualified clinician, often a hematologist, using the full clinical and laboratory picture.

Treatment Options

Hereditary Spherocytosis treatment is individualized according to age, symptom severity, hemoglobin level, degree of hemolysis, spleen size, gallstone complications, and overall health. Some people with mild disease need only periodic monitoring and education about warning signs. Others require more active treatment during childhood, infections, pregnancy, or episodes of severe anemia. The right approach is decided by a hematology specialist after careful assessment.

Supportive care may include regular follow-up blood tests and nutritional support for red blood cell production. Folic acid is sometimes recommended because the bone marrow may need extra folate to produce new red blood cells, but patients should use supplements only as advised by their doctor. Blood transfusion may be needed in selected situations, such as severe anemia in infancy, an aplastic crisis, or before certain procedures.

Surgery may be considered for some patients with moderate to severe disease. Splenectomy, removal of the spleen, can reduce red blood cell destruction and improve anemia, but it also increases lifelong infection risk from certain bacteria. Because of this, specialists carefully weigh the timing, risks, benefits, vaccination needs, and preventive measures. Partial splenectomy may be discussed in some settings, especially for children, but suitability depends on individual factors and local expertise.

Gallbladder management may be needed if pigment gallstones cause symptoms or complications. In some patients, gallbladder surgery may be considered, either separately or at the same time as spleen surgery when appropriate. Treatment decisions should not be based on symptoms alone; they require specialist evaluation, laboratory trends, imaging findings, and discussion with the patient or family.

Living With / Prognosis

Many people with Hereditary Spherocytosis do well with regular medical care and awareness of the condition. Long-term outlook depends on severity, complications, and whether treatments such as transfusion support, gallbladder care, or splenectomy are needed. Mild disease may have little impact on daily life, while moderate or severe disease may require closer monitoring and planning.

Living with the condition includes recognizing changes that may signal worsening anemia or complications. Patients and families are often advised to seek medical advice during significant infections, unexplained fever, increasing jaundice, severe tiredness, abdominal pain, or dark urine. Children may need monitoring of growth, development, and school activity tolerance. Adults may need additional guidance during pregnancy, major illness, travel, or planned surgery.

If the spleen has been removed or is not functioning well, infection prevention becomes especially important. Patients may need recommended vaccinations, awareness of fever as a medical warning sign, and individualized preventive measures based on local guidelines and specialist advice. They should inform healthcare providers about their splenectomy status before procedures, travel, or emergency care.

Genetic counseling can help families understand inheritance, testing options, and the chance of passing the condition to children. Emotional and practical support may also be valuable, especially for parents of newly diagnosed children. With a structured care plan and access to hematology follow-up, most patients can participate in normal family, school, work, and social activities.

When to See a Doctor

A doctor should be consulted if a person has unexplained anemia, repeated jaundice, an enlarged spleen, early gallstones, or a family history of Hereditary Spherocytosis. Children with persistent paleness, fatigue, yellow eyes, poor feeding, poor growth, or abdominal fullness should be assessed. Diagnosis is especially important because Hereditary Spherocytosis can resemble other blood disorders that require different management.

Urgent medical attention is needed for symptoms that may suggest severe anemia, infection, or gallbladder complications. These include fainting, chest discomfort, severe shortness of breath, fast or irregular heartbeat, high fever, marked drowsiness, rapidly worsening jaundice, severe abdominal pain, or very dark urine. People who have had a splenectomy should seek prompt medical care for fever or signs of infection.

Patients already diagnosed with Hereditary Spherocytosis should keep regular appointments with their hematology team, even when feeling well. Follow-up helps track hemoglobin, bilirubin, reticulocyte levels, spleen size, and gallstone risk. It also allows timely discussion of vaccinations, surgery, pregnancy planning, and family screening.

Acibadem International provides diagnosis and treatment for blood disorders, including Hereditary Spherocytosis, through multidisciplinary specialists in JCI-accredited hospitals for international patients. As with any medical condition, the most appropriate care plan should be based on an individual assessment by qualified healthcare professionals.

Frequently asked questions

What is Hereditary Spherocytosis?

Hereditary Spherocytosis is an inherited disorder of the red blood cell membrane. It makes red blood cells round and fragile, so they are removed too early by the spleen. This can cause hemolytic anemia, jaundice, and an enlarged spleen.

Is Hereditary Spherocytosis always inherited from a parent?

In many families, Hereditary Spherocytosis is inherited from an affected parent, often in an autosomal dominant pattern. However, some cases occur with no known family history because of a new genetic change or a less obvious inheritance pattern. Family testing and genetic counseling can help clarify risk.

What are the most common Hereditary Spherocytosis symptoms?

Common symptoms include fatigue, paleness, jaundice, dark urine during hemolysis, and an enlarged spleen. Some people develop pigment gallstones, which may cause abdominal pain or digestive symptoms. Mild cases may be discovered only during routine blood testing.

How is Hereditary Spherocytosis diagnosed?

Diagnosis usually involves a complete blood count, reticulocyte count, bilirubin level, blood smear, and tests that assess red blood cell membrane function. Doctors may also use a direct antiglobulin test to rule out autoimmune hemolytic anemia. Genetic testing may be helpful in selected cases, especially when the diagnosis is uncertain.

Can Hereditary Spherocytosis be cured?

Hereditary Spherocytosis is a lifelong genetic condition, so the underlying inherited tendency does not disappear. Treatments can reduce symptoms and complications, and splenectomy can greatly reduce red blood cell destruction in selected patients. Because splenectomy has important risks, it is considered only after specialist evaluation.

Do all patients with Hereditary Spherocytosis need spleen removal?

No. Many people with mild disease do not need splenectomy and are managed with monitoring and supportive care. Spleen removal may be considered for moderate or severe disease, recurrent complications, or significant anemia, but the decision depends on age, severity, infection risk, and specialist judgment.

Can a person with Hereditary Spherocytosis live a normal life?

Many people with Hereditary Spherocytosis live active and productive lives, especially when the condition is recognized and monitored. Regular follow-up helps detect anemia, gallstones, and other complications early. Patients should know when to seek medical care, particularly during infections or after spleen surgery.

References

• American Society of Hematology
• British Society for Haematology
• Merck Manual Professional Edition
• Orphanet
• National Organization for Rare Disorders

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.